---
title: "AMT - Complete Profile"
substance: "AMT"
chemical_name: "Œ±-Methyltryptamine"
category: "Psychedelic"
legal_status: "Schedule I (US) - Controlled substance"
description: "The long-duration tryptamine - AMT combines psychedelic visuals with stimulant energy over 12+ hour experiences"
permalink: "/dyos-domain/substances/amt/"
---

<div class="substance-profile-header">
  <div class="container">
    <nav class="breadcrumb">
      <a href="/dyos-domain/">Dyo's Domain</a> ‚Üí <a href="/dyos-domain/psychedelics/">Psychedelics</a> ‚Üí <span>AMT</span>
    </nav>
    
    <div class="substance-hero">
      <div class="substance-info">
        <h1>üåÄ AMT</h1>
        <h2 class="chemical-name">Œ±-Methyltryptamine</h2>
          
        <!-- Add to Profile Button -->
        <button id="add-to-profile-btn" class="add-to-profile-btn not-in-profile" 
                data-substance="AMT" 
                data-category="Psychedelics" 
                data-chemical="Œ±-Methyltryptamine">
          + Add to My Profile
        </button>
        
        <div class="alternative-names">
          <h3>Alternative Names & Slang</h3>
          <div class="names-grid">
            <div class="name-category">
              <h4>Common Names</h4>
              <span>AMT</span> ‚Ä¢ <span>Alpha-MT</span> ‚Ä¢ <span>Œ±MT</span> ‚Ä¢ <span>Spirals</span>
            </div>
            <div class="name-category">
              <h4>Chemical Names</h4>
              <span>Œ±-Methyltryptamine</span> ‚Ä¢ <span>Alpha-methyltryptamine</span> ‚Ä¢ <span>3-(2-Aminopropyl)indole</span>
            </div>
            <div class="name-category">
              <h4>Historical Names</h4>
              <span>Indopan</span> ‚Ä¢ <span>Monase</span> ‚Ä¢ <span>IT-290</span>
            </div>
            <div class="name-category">
              <h4>Street Names</h4>
              <span>Businessman's Trip</span> ‚Ä¢ <span>Foxy</span> ‚Ä¢ <span>IT</span> ‚Ä¢ <span>Tryptamine</span>
            </div>
          </div>
        </div>
        
        <div class="substance-meta-large">
          <span class="category psychedelic">Psychedelic</span>
          <span class="legal-status schedule-1">Schedule I</span>
          <span class="duration very-long">12-20 hours</span>
        </div>
      </div>
      
      <div class="substance-visual">
        <div class="substance-image">
          <img src="/assets/substances/amt.jpg" alt="AMT powder and capsules" class="substance-photo">
        </div>
        <div class="molecule-structure">
          <div class="structure-placeholder">
            <p>üß¨ C‚ÇÅ‚ÇÅH‚ÇÅ‚ÇÑN‚ÇÇ</p>
            <p>MW: 174.24 g/mol</p>
          </div>
        </div>
      </div>
    </div>
  </div>
</div>

<div class="container">
  
  <div class="profile-grid">
    
    <div class="profile-section identification">
      <h3>üîç Physical Identification</h3>
      <div class="identification-info">
        <div class="pure-form">
          <h4>Pure AMT (Freebase)</h4>
          <ul>
            <li><strong>Appearance:</strong> White to yellowish crystalline powder or crystals</li>
            <li><strong>Texture:</strong> Fine powder to small crystals, sticky when humid</li>
            <li><strong>Odor:</strong> Fishy, amine-like smell (characteristic of tryptamines)</li>
            <li><strong>Taste:</strong> Extremely bitter, metallic, lingering</li>
            <li><strong>Solubility:</strong> Moderately soluble in water, more soluble in acids</li>
          </ul>
        </div>
        
        <div class="salt-forms">
          <h4>Salt Forms</h4>
          <ul>
            <li><strong>AMT Fumarate:</strong> More stable, white crystalline salt</li>
            <li><strong>AMT Hydrochloride:</strong> Water-soluble salt form</li>
            <li><strong>AMT Acetate:</strong> Alternative salt preparation</li>
            <li><strong>Capsules:</strong> Often found in gelatin capsules (5-100mg doses)</li>
          </ul>
        </div>
        
        <div class="street-forms">
          <h4>Street Forms & Presentation</h4>
          <ul>
            <li><strong>Powder:</strong> Usually in small vials or bags</li>
            <li><strong>Capsules:</strong> Pre-measured doses in gel caps</li>
            <li><strong>Tablets:</strong> Less common, sometimes pressed tablets</li>
            <li><strong>Blotter:</strong> Rare but possible, usually research samples</li>
          </ul>
        </div>
        
        <div class="adulterants-warning">
          <h4>‚ö†Ô∏è Common Adulterants & Confusion</h4>
          <p><strong>Similar substances:</strong> 5-MeO-AMT, AET, other tryptamines</p>
          <p><strong>Research chemicals:</strong> Often mislabeled as other psychedelics</p>
          <p><strong>Adulterants:</strong> Inert fillers, other stimulants or psychedelics</p>
          <p><strong>Confusion risk:</strong> Often confused with shorter-acting psychedelics</p>
        </div>
      </div>
    </div>
    
    <div class="profile-section dosage">
      <h3>üíä Dosage Guidelines</h3>
      <div class="dosage-chart">
        <div class="dose-range threshold">
          <span class="range-label">Threshold</span>
          <span class="dose-amount">5-15mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range light">
          <span class="range-label">Light</span>
          <span class="dose-amount">15-25mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range common">
          <span class="range-label">Common</span>
          <span class="dose-amount">25-40mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range strong">
          <span class="range-label">Strong</span>
          <span class="dose-amount">40-60mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range heavy">
          <span class="range-label">Heavy/Dangerous</span>
          <span class="dose-amount">60mg+</span>
          <div class="dose-bar"></div>
        </div>
      </div>
      
      <div class="dosage-details">
        <h4>Critical Dosage Information</h4>
        <ul>
          <li><strong>First-time users:</strong> Start with 15-20mg maximum</li>
          <li><strong>Very long duration:</strong> 12-20 hours total experience</li>
          <li><strong>Steep dose-response:</strong> Small increases dramatically intensify effects</li>
          <li><strong>No redosing:</strong> Effects last so long that redosing is unnecessary and dangerous</li>
          <li><strong>Onset timing:</strong> Can take 1-3 hours, don't assume "it's not working"</li>
          <li><strong>Individual sensitivity:</strong> Varies dramatically between people</li>
        </ul>
      </div>
      
      <div class="route-specific">
        <h4>Route-Specific Information</h4>
        <ul>
          <li><strong>Oral:</strong> Standard route, full 12-20 hour duration</li>
          <li><strong>Insufflated:</strong> Faster onset, shorter duration, nasal irritation</li>
          <li><strong>Smoking/Vaporizing:</strong> Very fast onset, much shorter duration</li>
          <li><strong>Sublingual:</strong> Intermediate onset, may reduce nausea</li>
          <li><strong>Not recommended:</strong> IV or IM administration due to unknown safety profile</li>
        </ul>
      </div>
      
      <p class="dosage-note"><strong>Duration Warning:</strong> AMT's extremely long duration (12-20+ hours) makes it unsuitable for casual use. Plan for a full day commitment and potential next-day effects.</p>
    </div>

    <div class="profile-section effects">
      <h3>‚ú® Effects Profile</h3>
      
      <div class="effects-timeline">
        <h4>Timeline (oral administration)</h4>
        <div class="timeline-item">
          <span class="time">T+0:30-3:00</span>
          <span class="effect">Onset - stimulation, nausea, anxiety possible</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+3:00-8:00</span>
          <span class="effect">Peak - intense psychedelic and stimulant effects</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+8:00-16:00</span>
          <span class="effect">Plateau - sustained psychedelic state</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+16:00-24:00</span>
          <span class="effect">Comedown - gradual return, possible insomnia</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+24:00-48:00</span>
          <span class="effect">After-effects - fatigue, emotional processing</span>
        </div>
      </div>

      <div class="effects-categories">
        <div class="effect-category positive">
          <h4>‚úÖ Desired Effects</h4>
          <ul>
            <li>Intense visual hallucinations and distortions</li>
            <li>Enhanced pattern recognition and fractals</li>
            <li>Increased energy and stimulation</li>
            <li>Euphoria and mood elevation</li>
            <li>Enhanced introspection and self-analysis</li>
            <li>Synesthesia and sensory mixing</li>
            <li>Time distortion and altered perception</li>
            <li>Enhanced creativity and novel thinking</li>
            <li>Spiritual or mystical experiences</li>
          </ul>
        </div>
        
        <div class="effect-category neutral">
          <h4>‚öñÔ∏è Neutral/Variable Effects</h4>
          <ul>
            <li>Pupil dilation (mydriasis)</li>
            <li>Increased heart rate and blood pressure</li>
            <li>Body temperature fluctuations</li>
            <li>Muscle tension and jaw clenching</li>
            <li>Altered appetite (usually suppressed)</li>
            <li>Heightened sensory perception</li>
            <li>Emotional intensity and lability</li>
            <li>Altered sleep patterns</li>
          </ul>
        </div>
        
        <div class="effect-category negative">
          <h4>‚ùå Negative Effects & Risks</h4>
          <ul>
            <li>Severe nausea and vomiting (especially onset)</li>
            <li>Anxiety, panic, and paranoia</li>
            <li>Overwhelming sensory input</li>
            <li>Insomnia and sleep disruption</li>
            <li>Physical exhaustion from long duration</li>
            <li>Difficult or "bad trip" experiences</li>
            <li>Confusion and disorientation</li>
            <li>Dehydration and overheating</li>
            <li>Risk of dangerous behavior due to altered perception</li>
            <li>Next-day depression or emotional instability</li>
          </ul>
        </div>
      </div>

      <div class="dose-response">
        <h4>üìä Dose-Response Relationship</h4>
        <ul>
          <li><strong>15-25mg:</strong> Mild psychedelic effects, some stimulation, manageable experience</li>
          <li><strong>25-40mg:</strong> Full psychedelic experience with strong visuals and mental effects</li>
          <li><strong>40-60mg:</strong> Intense, potentially overwhelming experience with high risk</li>
          <li><strong>60mg+:</strong> Dangerous territory - risk of severe psychological trauma</li>
          <li><strong>Tolerance:</strong> Develops rapidly, cross-tolerance with other psychedelics</li>
        </ul>
      </div>
    </div>

    <div class="profile-section pharmacology">
      <h3>üß† Pharmacology & Neuroscience</h3>
      <div class="pharma-details">
        <h4>Primary Mechanism of Action</h4>
        <p>AMT is a complex tryptamine that acts primarily as a serotonin releasing agent and reuptake inhibitor, particularly at SERT transporters, while also showing activity at multiple serotonin receptor subtypes. Unlike classic psychedelics that primarily work through 5-HT2A agonism, AMT combines monoamine release with direct receptor activation, creating its unique stimulant-psychedelic profile.</p>
        
        <h4>Detailed Receptor Pharmacology</h4>
        <div class="receptor-table">
          <div class="receptor-row">
            <span class="receptor-name"><strong>SERT (5-HT transporter)</strong></span>
            <span class="affinity">High affinity releasing agent</span>
            <span class="function">Primary mechanism - serotonin release and reuptake inhibition</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>5-HT2A receptor</strong></span>
            <span class="affinity">Moderate to high agonist activity</span>
            <span class="function">Visual hallucinations, altered consciousness</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>5-HT2C receptor</strong></span>
            <span class="affinity">Agonist activity</span>
            <span class="function">Appetite suppression, mood effects</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>5-HT1A receptor</strong></span>
            <span class="affinity">Partial agonist</span>
            <span class="function">Anxiolytic effects, body load modulation</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>NET/DAT</strong></span>
            <span class="affinity">Moderate activity</span>
            <span class="function">Stimulant effects, energy, focus</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>MAO-A inhibition</strong></span>
            <span class="affinity">Weak reversible inhibitor</span>
            <span class="function">Extends duration, increases effects of other monoamines</span>
          </div>
        </div>

        <h4>Metabolism & Pharmacokinetics</h4>
        <div class="metabolism-details">
          <p><strong>Primary Pathway:</strong> Hepatic metabolism via MAO-A and MAO-B ‚Üí indoleacetic acid derivatives</p>
          <p><strong>Half-life:</strong> 3-5 hours (but effects last much longer due to active metabolites)</p>
          <p><strong>Bioavailability:</strong> ~60-80% oral administration</p>
          <p><strong>Peak plasma:</strong> 2-4 hours after oral dose</p>
          <p><strong>Active metabolites:</strong> Several identified, contributing to long duration</p>
          <p><strong>Elimination:</strong> Primarily urinary, complete clearance takes 24-48 hours</p>
          <p><strong>Duration factors:</strong> Individual MAO enzyme activity affects experience length</p>
        </div>

        <h4>Unique Pharmacological Properties</h4>
        <div class="unique-properties">
          <p><strong>Dual mechanism:</strong> Both monoamine releasing agent and direct receptor agonist</p>
          <p><strong>MAO inhibition:</strong> Weak inhibition contributes to extended duration</p>
          <p><strong>Active metabolites:</strong> Metabolites may have psychoactive properties extending effects</p>
          <p><strong>Stimulant-psychedelic combination:</strong> Unusual profile mixing tryptamine psychedelia with amphetamine-like stimulation</p>
          <p><strong>Individual variation:</strong> Extreme individual differences in response and duration</p>
        </div>

        <h4>Neurotransmitter Systems Affected</h4>
        <ul>
          <li><strong>Serotonin system:</strong> Primary target - massive release and receptor activation</li>
          <li><strong>Dopamine system:</strong> Moderate activity contributing to stimulant effects</li>
          <li><strong>Norepinephrine system:</strong> Secondary activity causing alertness and energy</li>
          <li><strong>GABA system:</strong> Indirect effects through serotonin modulation</li>
          <li><strong>Glutamate system:</strong> Potential indirect effects on consciousness</li>
        </ul>
      </div>
    </div>

    <div class="profile-section safety">
      <h3>‚ö†Ô∏è Safety & Harm Reduction</h3>
      
      <div class="safety-grid">
        <div class="safety-item critical">
          <h4>üö® Critical Warnings</h4>
          <ul>
            <li><strong>Extremely long duration:</strong> 12-20+ hour commitment required</li>
            <li><strong>Intense nausea:</strong> Severe vomiting possible, risk of dehydration</li>
            <li><strong>Cardiovascular stress:</strong> Prolonged increased heart rate and blood pressure</li>
            <li><strong>Psychological intensity:</strong> Risk of severe anxiety, panic, or psychotic episodes</li>
            <li><strong>Sleep disruption:</strong> May prevent sleep for 24+ hours</li>
            <li><strong>Individual variability:</strong> Extreme differences in sensitivity and response</li>
          </ul>
        </div>
        
        <div class="safety-item precautions">
          <h4>üõ°Ô∏è Essential Harm Reduction</h4>
          <ul>
            <li>Clear schedule for 24-48 hours (no responsibilities)</li>
            <li>Experienced trip sitter mandatory for first use</li>
            <li>Safe, comfortable environment with no obligations</li>
            <li>Start with very low dose (15-20mg maximum)</li>
            <li>Anti-nausea medication available (ondansetron, ginger)</li>
            <li>Stay hydrated but avoid excessive water intake</li>
            <li>Have benzodiazepines available for emergencies</li>
            <li>No driving or dangerous activities for 24+ hours</li>
          </ul>
        </div>
      </div>

      <div class="contraindications">
        <h4>üö´ Absolute Contraindications</h4>
        <ul>
          <li>Heart conditions, high blood pressure, or cardiovascular disease</li>
          <li>History of psychosis, schizophrenia, or severe mental illness</li>
          <li>Current use of antidepressants (SSRIs, MAOIs, tricyclics)</li>
          <li>Pregnancy or breastfeeding</li>
          <li>History of seizure disorders</li>
          <li>Severe anxiety or panic disorders</li>
          <li>Recent use of other psychedelics or stimulants</li>
          <li>Inability to commit to 24+ hour experience</li>
        </ul>
      </div>

      <div class="emergency-info">
        <h4>üö® Emergency Information</h4>
        <p><strong>Overdose symptoms:</strong> Severe hyperthermia, seizures, cardiac arrhythmias, extreme agitation</p>
        <p><strong>Psychological crisis:</strong> Severe panic, psychotic symptoms, self-harm risk</p>
        <p><strong>Emergency protocol:</strong> Call emergency services, provide supportive care, consider benzodiazepines</p>
        <p><strong>Medical info:</strong> Inform medical professionals of AMT use and timing</p>
      </div>
    </div>

    <div class="profile-section interactions">
      <h3>‚öóÔ∏è Drug Interactions</h3>
      
      <div class="interaction-levels">
        <div class="interaction dangerous">
          <h4>üî¥ Extremely Dangerous</h4>
          <ul>
            <li><strong>MAOIs:</strong> Risk of serotonin syndrome and hypertensive crisis - potentially fatal</li>
            <li><strong>SSRIs/SNRIs:</strong> Severe serotonin syndrome risk, especially with AMT's long duration</li>
            <li><strong>Tramadol:</strong> Multiple mechanisms increase serotonin syndrome risk</li>
            <li><strong>DXM:</strong> Both affect serotonin system - dangerous combination</li>
            <li><strong>Stimulants:</strong> Extreme cardiovascular stress over 12-20 hours</li>
          </ul>
        </div>
        
        <div class="interaction risky">
          <h4>üü° High Risk</h4>
          <ul>
            <li><strong>Other psychedelics:</strong> Unpredictable interactions, extreme duration</li>
            <li><strong>Cannabis:</strong> May intensify effects and anxiety, especially during long experience</li>
            <li><strong>Alcohol:</strong> Dangerous with stimulant effects, masks intoxication</li>
            <li><strong>Benzodiazepines:</strong> May be needed for emergencies but can be unpredictable</li>
            <li><strong>Tricyclic antidepressants:</strong> Increased serotonin activity</li>
          </ul>
        </div>
        
        <div class="interaction caution">
          <h4>üü† Use Extreme Caution</h4>
          <ul>
            <li><strong>Nitrous oxide:</strong> May intensify effects, risk of falls during long experience</li>
            <li><strong>Caffeine:</strong> Additional cardiovascular stress over extended period</li>
            <li><strong>Nicotine:</strong> Increased stimulant effects and cardiovascular strain</li>
            <li><strong>St. John's Wort:</strong> Natural MAO inhibition may intensify effects</li>
          </ul>
        </div>
      </div>

      <div class="interaction-timing">
        <h4>‚è∞ Timing Considerations</h4>
        <ul>
          <li><strong>SSRI/SNRI washout:</strong> Minimum 2-4 weeks before AMT use</li>
          <li><strong>MAOI washout:</strong> Minimum 2 weeks before AMT use</li>
          <li><strong>Previous psychedelic use:</strong> Wait at least 1-2 weeks for tolerance reset</li>
          <li><strong>After AMT:</strong> Wait minimum 2 weeks before other psychedelics</li>
        </ul>
      </div>
    </div>

    <div class="profile-section legal">
      <h3>‚öñÔ∏è Legal Status</h3>
      <div class="legal-info">
        <div class="legal-jurisdictions">
          <div class="jurisdiction">
            <h4>üá∫üá∏ United States</h4>
            <p><strong>Schedule I</strong> - Controlled since 2003. Illegal to manufacture, possess, or distribute. No accepted medical use.</p>
          </div>
          <div class="jurisdiction">
            <h4>üá¨üáß United Kingdom</h4>
            <p><strong>Class A</strong> - Controlled under Misuse of Drugs Act. Up to 7 years for possession, life for supply.</p>
          </div>
          <div class="jurisdiction">
            <h4>üá™üá∫ European Union</h4>
            <p><strong>Controlled substance</strong> - Most EU countries have banned AMT following safety concerns and deaths.</p>
          </div>
          <div class="jurisdiction">
            <h4>üåè International</h4>
            <p><strong>Widely controlled</strong> - Most countries have placed AMT under controlled substance laws following reports of adverse effects.</p>
          </div>
        </div>
        
        <div class="legal-history">
          <h4>‚öñÔ∏è Legal History</h4>
          <p>AMT was emergency scheduled in the US in 2003 following several deaths and hospitalizations. The extremely long duration and unpredictable effects led to rapid international control measures.</p>
        </div>
      </div>
    </div>

    <div class="profile-section history">
      <h3>üìö History & Culture</h3>
      
      <div class="history-timeline">
        <div class="history-event">
          <span class="year">1950s</span>
          <p>First synthesized and studied as potential antidepressant by Upjohn Company</p>
        </div>
        <div class="history-event">
          <span class="year">1961</span>
          <p>Briefly marketed as "Indopan" antidepressant, withdrawn due to side effects</p>
        </div>
        <div class="history-event">
          <span class="year">1990s</span>
          <p>Alexander Shulgin includes AMT in PiHKAL, describing psychoactive properties</p>
        </div>
        <div class="history-event">
          <span class="year">Early 2000s</span>
          <p>Emerges in research chemical market, sold online as "legal psychedelic"</p>
        </div>
        <div class="history-event">
          <span class="year">2003</span>
          <p>Emergency scheduled in US following deaths and adverse events</p>
        </div>
        <div class="history-event">
          <span class="year">2003-2005</span>
          <p>International control measures implemented worldwide</p>
        </div>
      </div>

      <div class="cultural-impact">
        <h4>Cultural Impact & Legacy</h4>
        <p>AMT's brief period of legal availability in the early 2000s made it notorious among psychonaut communities for its extremely long duration and intense effects. Reports of people being "stuck" in trips for 20+ hours led to its reputation as one of the most challenging psychedelics available.</p>
        
        <h4>Research Chemical Era</h4>
        <p>AMT exemplified the risks of the early internet-based research chemical market, where substances with minimal human use data were sold with little safety information. Its emergency scheduling helped establish precedents for rapid control of dangerous novel psychoactive substances.</p>
      </div>
    </div>

    <div class="profile-section research">
      <h3>üî¨ Research & Medical History</h3>
      
      <div class="research-areas">
        <div class="research-item">
          <h4>Historical Medical Use</h4>
          <p>AMT was briefly marketed as "Indopan" for depression in the early 1960s but was withdrawn due to severe side effects and unpredictable responses. This represents one of the few attempts to use tryptamines medically.</p>
        </div>
        
        <div class="research-item">
          <h4>Pharmacological Studies</h4>
          <p>Limited research exists on AMT's pharmacology, primarily focused on understanding its dual releasing agent and receptor agonist properties. Most data comes from in vitro studies and user reports.</p>
        </div>
        
        <div class="research-item">
          <h4>Toxicology Research</h4>
          <p>Case studies of AMT-related deaths and hospitalizations have provided insight into its toxicological profile, particularly cardiovascular and hyperthemic risks.</p>
        </div>
        
        <div class="research-item">
          <h4>Current Status</h4>
          <p>No current legitimate research due to Schedule I status and safety profile. AMT remains primarily of forensic and toxicological interest rather than therapeutic potential.</p>
        </div>
      </div>

      <div class="medical-concerns">
        <h4>üè• Medical Concerns</h4>
        <ul>
          <li><strong>Emergency department presentations:</strong> Prolonged psychosis, hyperthermia, cardiovascular complications</li>
          <li><strong>Death reports:</strong> Several documented deaths from hyperthermia and cardiovascular failure</li>
          <li><strong>Long-term effects:</strong> Limited data on persistent effects from extremely long experiences</li>
          <li><strong>No therapeutic use:</strong> No accepted medical applications in modern medicine</li>
        </ul>
      </div>
    </div>

  </div>

  <div class="substance-resources">
    <h3>üìñ Additional Resources</h3>
    <div class="resources-grid">
      <div class="resource-item">
        <h4>Harm Reduction</h4>
        <ul>
          <li><a href="https://psychonautwiki.org/">PsychonautWiki</a> - Detailed pharmacology and effects</li>
          <li><a href="https://erowid.org/">Erowid</a> - Experience reports and information</li>
          <li><a href="https://bluelight.org/">Bluelight</a> - Harm reduction community</li>
          <li><a href="https://tripsit.me/">TripSit</a> - Crisis support and information</li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Emergency Resources</h4>
        <ul>
          <li><strong>Emergency Services:</strong> Call 911/emergency services for medical crisis</li>
          <li><strong>Poison Control:</strong> 1-800-222-1222 (US) for overdose information</li>
          <li><strong>Crisis Text Line:</strong> Text HOME to 741741</li>
          <li><strong>TripSit IRC:</strong> Real-time crisis support chat</li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Scientific Resources</h4>
        <ul>
          <li><a href="https://pubmed.ncbi.nlm.nih.gov/">PubMed</a> - Medical research database</li>
          <li><a href="https://maps.org/">MAPS</a> - Psychedelic research organization</li>
          <li>Shulgin, A. & Shulgin, A. - PiHKAL (historical reference)</li>
          <li>Forensic toxicology journals for case studies</li>
        </ul>
      </div>
    </div>
  </div>

  <div class="danger-footer">
    <h3>‚ö†Ô∏è Final Warning</h3>
    <p>AMT is considered one of the most challenging and potentially dangerous psychedelics available. Its extremely long duration (12-20+ hours), intense effects, history of deaths and hospitalizations, and steep dose-response curve make it unsuitable for most users. The combination of psychedelic and stimulant effects over such an extended period creates unique risks not found with other substances.</p>
    
    <p><strong>If you are considering AMT use, please thoroughly research harm reduction, ensure you have 24+ hours completely free, experienced supervision, and emergency medical support available. Many experienced psychonauts consider AMT too risky for recreational use.</strong></p>
  </div>

</div>